# AI lab chiefs ask Congress to mandate synthetic-DNA screening
> Altman, Amodei, Hassabis and 60+ others back a law to screen and log nucleic-acid orders as AI tops PhD virologists on lab questions

**Meta:** type: event · date: 2026-06-04 · heads: Quién decide, Lo que no dicen · 12 takes · 3 lenses · 4 regions

## Summary

On 4 June 2026, more than 60 AI and national-security figures, including [Sam Altman](/es/entity/openai), [Dario Amodei](/es/entity/anthropic), [Demis Hassabis](/es/entity/google-deepmind), Mustafa Suleyman, Alexandr Wang and protein-design pioneer David Baker, signed "An Open Letter in Support of Mandatory Nucleic Acid Synthesis Screening and Recordkeeping" (screendna.org). It asks Congress to require [synthetic-DNA/RNA](/es/entity/dna-synthesis) vendors to screen orders against dangerous sequence motifs and keep records so investigators can trace split, individually-benign orders. The trigger: frontier AI now outperforms PhD-level virologists on many technical lab questions, eroding the knowledge barrier. Two bills compete, H.R. 3029 (voluntary-leaning) and S. 3741, the Biosecurity Modernization and Innovation Act, which would mandate Commerce Department rules. [IBBIS](/es/entity/ibbis) is advancing the underlying ISO standards.

## By the numbers

- 60+, signatories (AI lab chiefs, scientists, security figures).
- 4 Jun 2026, letter published.
- ~20%, share of the global synthesis market outside voluntary screening frameworks.
- 36 of 38, synthesis providers that shipped 1918-flu fragments undetected in an FBI-overseen red-team.
- 2, competing bills (H.R. 3029 voluntary; S. 3741 mandatory).

## Why it matters

This is the AI×biology intersection turning into law-shaped pressure: the same labs building biological design tools want the synthesis chokepoint regulated before their models lower the barrier further. A mandate would reshape a fragmented global DNA-supply market and set whether AI-generated sequences get caught at the order desk.

## What to watch

- Movement on S. 3741 vs H.R. 3029 in committee.
- Whether screening rules cover AI-generated/novel sequences, not just known pathogens.
- Adoption of IBBIS/ISO TC 276 standards by major synthesis vendors.

## Regional takes (batched by bias / lens)

### unlabelled
- **screendna.org (the open letter)** (United States, en) — Primary text: 'An Open Letter in Support of Mandatory Nucleic Acid Synthesis Screening and Recordkeeping', signed 4 Jun 2026 by AI lab chiefs and scientists, calling for mandatory sequence screening against dangerous motifs before synthesis ships, plus mandatory order recordkeeping to trace multi-part orders.
  Source: https://screendna.org/
- **IBBIS (screening standards)** (Switzerland, en) — IBBIS's DNA Synthesis Screening Consortium update: granted Category A liaison status with ISO TC 276, advancing international customer- and sequence-screening standards that a US mandate would lean on.
  Source: https://ibbis.bio/international-meeting-advances-standards-for-dna-synthesis-screening/
- **Interesting Engineering** (United States, en) — 
  Source: https://interestingengineering.com/ai-robotics/ai-biosecurity-open-letter-dna-screening-policy
- **Crypto Briefing** (Global, en) — 
  Source: https://cryptobriefing.com/openai-anthropic-congress-synthetic-dna-regulation/
- **Ground News** (United States, en) — 
  Source: https://ground.news/article/top-ai-ceos-urge-congress-to-mandate-dna-screening_074163
- **NSCEB Newsletter (US Senate)** (United States, en) — 
  Source: https://www.biotech.senate.gov/press-releases/nsceb-monthly-newsletter-june-2026/
- **GCBR Organization Updates** (Global, en) — 
  Source: https://gcbrupdates.substack.com/p/gcbr-organization-updates-june-2026
- **NTI (Risky Business)** (United States, en) — 
  Source: https://www.nti.org/risky-business/a-simple-step-to-close-a-dangerous-biosecurity-gap/
- **Science (AAAS)** (United States, en) — 
  Source: https://www.science.org/doi/10.1126/science.adu8578
- **CSIS** (United States, en) — 
  Source: https://www.csis.org/analysis/opportunities-strengthen-us-biosecurity-ai-enabled-bioterrorism-what-policymakers-should

### tech / skeptical
- **The Register** (United Kingdom, en) — Reports the letter and notes the labs' own admission that evidence on immediate capability is 'mixed', framing the warning as AI firms simultaneously selling and policing the risk; cites AI now topping PhD-level virologists on technical lab questions.
  > "AI heavyweights warn their tech could help terrorists develop bioweapons."
  Source: https://www.theregister.com/ai-and-ml/2026/06/04/ai-heavyweights-warn-their-tech-could-erode-barriers-to-bioweapons/

### business / policy
- **Quartz** (United States, en) — Frames the call around the competing bills, H.R. 3029 (voluntary-leaning standards) and S. 3741 (mandatory Commerce Department rules), and the politics of regulating a $-billions synthesis market where ~20% operates outside voluntary frameworks.
  > "OpenAI, Anthropic, Google CEOs call for DNA screening law."
  Source: https://qz.com/ai-ceos-synthetic-dna-screening-bioweapons-congress-060526

## Across the graph
- Related: [[isomorphic-labs-series-b-2026]], [[evo2-generative-genome-2026]], [[ai-safety-report-2026]]
- Entities: Dna Synthesis, Biosecurity, Ibbis, Openai, Anthropic, Google Deepmind

---
Canonical: https://rbtfl.xyz/es/n/dna-synthesis-screening-letter-2026